Quantitative determination of lercanidipine enantiomers in commercial formulations by capillary electrophoresis
- PMID: 25821632
- PMCID: PMC4363879
- DOI: 10.1155/2015/294270
Quantitative determination of lercanidipine enantiomers in commercial formulations by capillary electrophoresis
Abstract
An enantioselective method based on capillary electrophoresis (CE) using cyclodextrin (CD) as chiral selector was developed and validated for determination of lercanidipine (LER) enantiomers, a drug calcium channel blocker which exerts antihypertensive effects of long duration, in a pharmaceutical formulation. Optimum separation of LER enantiomers was obtained on a 50 cm × 50 μm id capillary using a sodium acetate buffer solution 200 mmol/L pH 4.0 containing 10 mmol/L of 2,3,6-o-methyl-β-cyclodextrin (TM-β-CD) as background electrolyte. The capillary temperature and voltage were 15°C and 25 kV, respectively, hydrodynamic injection and detection at 237 nm. Linearity was obtained in the range 12.5-100 μg/mL for both enantiomers (r ≥ 0.995). The RSD (%) and relative errors (E, %) obtained in precision and accuracy studies (intraday and interday) were lower than 5%. After validation, the method was applied to quantify the enantiomers of LER in commercial tablets and the results were satisfactory in terms of accuracy and precision, both less than 5%. Therefore, this method was found to be appropriate for enantioselective quality control of LER enantiomers in pharmaceutical formulations.
Figures





Similar articles
-
Capillary electrophoresis method for the determination of isradipine enantiomers: stability studies and pharmaceutical formulation analysis.Electrophoresis. 2011 Oct;32(19):2673-82. doi: 10.1002/elps.201100166. Electrophoresis. 2011. PMID: 21983818
-
Enantiomeric separation of meptazinol and its three intermediate enantiomers by capillary electrophoresis: quantitative analysis of meptazinol in pharmaceutical formulations.Biomed Chromatogr. 2014 Jan;28(1):135-41. doi: 10.1002/bmc.2997. Epub 2013 Jul 25. Biomed Chromatogr. 2014. PMID: 23893795
-
Development of a capillary electrophoresis method for the enantioselective estimation of primaquine in pharmaceutical formulations.J AOAC Int. 2008 May-Jun;91(3):536-41. J AOAC Int. 2008. PMID: 18567298
-
Determination of aminoglutethimide enantiomers in pharmaceutical formulations by capillary electrophoresis using methylated-beta-cyclodextrin as a chiral selector and computational calculation for their respective inclusion complexes.Talanta. 2009 Feb 15;77(4):1388-93. doi: 10.1016/j.talanta.2008.09.029. Epub 2008 Sep 27. Talanta. 2009. PMID: 19084654
-
Enantioselective analysis of ofloxacin and ornidazole in pharmaceutical formulations by capillary electrophoresis using single chiral selector and computational calculation of their inclusion complexes.Anal Chim Acta. 2010 Aug 3;674(2):249-55. doi: 10.1016/j.aca.2010.06.046. Epub 2010 Jul 6. Anal Chim Acta. 2010. PMID: 20678638
Cited by
-
Development of three ecological spectroscopic methods for analysis of betrixaban either alone or in mixture with lercanidipine: greenness assessment.R Soc Open Sci. 2022 Feb 2;9(2):211457. doi: 10.1098/rsos.211457. eCollection 2022 Feb. R Soc Open Sci. 2022. PMID: 35127114 Free PMC article.
-
Cyclodextrin Inclusion Complexes for Improved Drug Bioavailability and Activity: Synthetic and Analytical Aspects.Pharmaceutics. 2023 Sep 19;15(9):2345. doi: 10.3390/pharmaceutics15092345. Pharmaceutics. 2023. PMID: 37765313 Free PMC article. Review.
References
-
- Notarbartolo A., Rengo F., Scafidi V., Acanfora D. Long-term effects of lercanidipine on the lipoprotein and apolipoprotein profile of patients with mild-to-moderate essential hypertension. Current Therapeutic Research: Clinical and Experimental. 1999;60(4):228–236. doi: 10.1016/s0011-393x(00)88518-5. - DOI
-
- Godfraind T. Classification of calcium antagonists. The American Journal of Cardiology. 1987;59(3):11B–23B. - PubMed
-
- Goodman G. A., Rall T. W., Tweenies A. S., Taylor P. The Pharmacological Basis of Therapeutics. 9th. New York, NY, USA: McGraw-Hill:; 1992.
-
- Buckley N., Dawson A., Whyte I. Calcium channel blockers. Medicine. 2007;35(11):599–602. doi: 10.1016/j.mpmed.2007.08.025. - DOI
LinkOut - more resources
Full Text Sources
Other Literature Sources